Goooooooood Morning Everyone--- I've got a wicked headache from not sleeping right, well from not sleeping! Up since Midnight so pardon me if I quickly give you today's best ideas. 1-Guardant Health price target raised by $5 at Scotiabank, here's why » 07:07 GH reason: Last week nobody noticed but analysts were raising price targets like crazy I think I counted five~~~ That's positive penguin action. GH is a Buy. 2-BioCryst sees annual CAGR for revenue of around 20% over next three years » 07:07 BCRX reason: I just like this name on their positive revenue from existing drugs with a Bird Flu kicker. 3-Wallbox receives $10M investment » 06:52 WBX reason: These guys as I remember are foreign. Travere Therapeutics price target raised by $4 at Citi, here's why » 06:42 TVTX Citi raised reason: Continued drumbeat here... Snowflake price target raised by $7 at Bernstein, here's why » 06:18 SNOW reason: This is my #1 play of the week. SNOW is a buy. Waystar price target raised by $8 at Canaccord, here's why » 06:15 WAY reason: we have an ongoing gummy here/ we added at the secondary she should begin to move up now. WAY is a buy.
Ok now for Van.. please remember I aM using the Lumen handbook. Van you have been placed in the sandbox. You will be able to earn your way out with good behavior. You have been placed in the sandbox for bad behavior. The list of your transgressions are as follows: 1- Using too many words. 2- Threatening and or wishing death upon Elite Traders 3- Acting in a non professional manner These are the steps we must unwind. The Lumen handbook provides a series of names that I am to ask you your opinion on. Try and think how these names can provide an outlook for investing. YOUR FIRST NAME::: CAPABILITY BROWN
What a slap in that gay bearded guy's face--- Germany's next chancellor Merz calls for 'real independence' from Trump's U.S. EWG-0.77%Today, 3:18 AM
Elon Musk’s DOGE laying off workers at the auto safety agency overseeing Tesla - report Nvidia likely to offer up 'clear beat and raise' with Q4 results, guidance: Wedbush
I'm getting worried about the smoke here-- Last week the energy providers for data centers took a huge hit. Why? Could there be less demand... Today: Microsoft said to be canceling leases for AI datacenters WE could be setting up for the big short here-- which is bad news for APLD....
German Stocks Beat Peers as Merz’s Vote Win Spurs Spending Bets- Man I am mad at myself. I used to have the most beautiful German defense play but it returned 4X any American defense stock and I sold it... FOMO- I never have it never have but I'm starting to feel it... WE need Europe ideas!!!!!
Good Morning Stoney and all! Stoney do you ever eat Mexican food or does New York not have the same level we have in Southern California? “ Headlines: Pedro Pascal Says “There’s No Good Mexican Food In New York” On ‘Hot Ones’ By Lexis-Olivier Ray 10:52 AM PST on March 10, 2023” In my spam box and social media scanning device TMC(The Metals Company) is getting promoted heavily, I don’t know it like you. Personally I will wait for volume and more excitement before acting on it.
Key Communication Services Stock Picks Infrastrutture Wireless Italiane BT Group Key Morningstar Metrics for BT Group Analyst: Javier Correonero Morningstar Rating: ★★★★ Fair Value Estimate: GBX 190.00 Economic Moat: Narrow Javier Correonero, equity analyst at Morningstar, thinks BT, is a promising investment. Its relationship with the UK’s regulator Ofcom has improved signaling reduced regulatory intervention. Openreach, the company BT owns, is also expected to bring in higher free cash flow. Meanwhile, BT will reduce its headcount to ensure cost controls which are paramount in the telecommunications industry. Key Morningstar Metrics for Infrastrutture Wireless Italiane Analyst: Javier Correonero Morningstar Rating: ★★★★★ Fair Value Estimate: EUR 12.60 Economic Moat: Narrow Infrastrutture Wireless Italiane, the Italian telecoms multi-operator, is backed by Morningstar for the quality of its tower portfolio, as it has the two largest mobile operators in Italy. The company, commonly known as Intwit, has contracts that provide it with best-in-class inflation protection. Morningstar also likes that its dividends are projected to grow in the mid-to-high single digits. Key Consumer Cyclical Stock Picks Persimmon Zalando Kering The consumer cyclicals sector is currently attractively valued. Key Morningstar Metrics for Persimmon Analyst: Grant Slade, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: GBX 2300.00 Economic Moat: None Grant Slade, senior equity analyst at Morningstar, backs UK housebuilder Persimmon, arguing that the UK housing market is in the early stages of a cyclical recovery. We looked at the prospect forUK housingandmortgagesin two recent articles. Key Morningstar Metrics for Zalando SE Analyst:Jelena Sokolova, CFA Morningstar Rating: ★★★★ Fair Value Estimate: EUR 42.70 Economic Moat: None German apparel retail supplier is benefiting from its strong balance sheet to weather the sector downturn. Key Morningstar Metrics for Kering Analyst: Jelena Sokolova, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: EUR 448.00 Economic Moat: Narrow Gucci owner Kering was one of the luxury goods names hit by weak Chinese consumer sentiment last year. However, Kering is a top stock pick because it has a significant presence in leather goods, its flagship brand Gucci is strong globally, and it owns smaller brands in the business with the potential to expand. Key Consumer Defensive Stock Picks Pernod Ricard British American Tobacco Reckitt Benckiser Consumers have shown they are much more selective in what they are purchasing which has created a tough landscape for larger brands going into 2025. Key Morningstar Metrics For Pernod Ricard Analyst: Verushka Shetty Morningstar Rating: ★★★★ Fair Value Estimate: EUR 129.00 Economic Moat: Wide Verushka Shetty, equity analyst at Morningstar, backs the business for its extensive portfolio and strong innovation pipeline, priming it to dominate growing markets like India. Its products also fall into an affordable luxury category meaning it should benefit from long-term demand growth thanks to premiumization. Key Morningstar Metrics For British American Tobacco Analyst: Kristoffer Inton Morningstar Rating: ★★★★ Fair Value Estimate: GBX 3900.00 Economic Moat: Wide BATS has invested in several next-generation products that can deliver nicotine with reduced risk, as global cigarette consumption is declining. Kristoffer Inton, equity analyst at Morningstar, sees this strategy as leading to the cigarette behemoth becoming a “jack of all trades, master of none.” However, despite the challenges in its next-generation portfolio, Inton is confident BAT will remain profitable, as it holds several cigarette brands with high market shares, particularly in the US. Key Morningstar Metrics for Reckitt Benckiser Group Analyst: Diana Radu, CFA Morningstar Rating: ★★★★ Fair Value Estimate: GBX 6500.00 Economic Moat: Wide Reckitt Benckiser’s portfolio is well-positioned to benefit from secular growth drivers across consumer health and hygiene. The company’s acquisition of Mead Johnson has allowed Reckitt to expand into infant nutrition – a sector with strong pricing power. In comparison, with some of its competitors, the brand has no real exposure to laundry care, which Morningstar feels explains its higher operating margin of low 20s compared with high teens for its peers. Key Energy Sector Stock Picks Shell BP Key Morningstar Metrics for Shell Analyst: Allen Good, CFA Morningstar Rating: ★★★ Fair Value Estimate: GBX 2900.00 Economic Moat: None Backers of Shell believe the business will benefit from a rise in demand for gas around the world as LNG becomes much more important over the next decade. Shell’s new CEO has also slowed down its green transition strategy and refocused the company on capital discipline and returns. Key Morningstar Metrics For BP Analyst: Allen Good, CFA Morningstar Rating: ★★★★ Fair Value Estimate: GBX 490.00 Economic Moat: None In Allen Good’s view, BP adapting well to the green energy transition. It is moving away from investments in oil which could better position it for success than its peers over the next decade. However, the company will keep its hydrocarbon production at current levels. This decision will ensure BP continues its leverage to commodity prices which will strengthen cash flow for shareholders. Key Financial Services Stock Picks BNP Paribas Prudential UK Adyen Morningstar analysts expect central banks to continue to cut interest rates this year. Higher interest rates have enhanced European banks' profitability, but the upcoming decline in rates is not expected to dent banks' success in 2025. Key Morningstar Metrics For BNP Paribas Analyst: Johann Scholtz, CFA Morningstar Rating: ★★★★ Fair Value Estimate: EUR 85.00 Economic Moat: None BNP Paribas BNP has reported consistent earnings over the past decade, whilst its peers have experienced earnings volatility. As we enter a return to normal monetary policy in the Eurozone, Morningstar expects a structural increase in BNP Paribas’ profitability. Therefore, the French bank is viewed as a less risky investment opportunity because of its stable track record. Key Morningstar Metrics For Prudential UK Analyst: Henry Heathfield, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: GBX 1200.00 Economic Moat: None Prudential UK has divested from its UK, European, and North American operations. It is now a life and health insurer fully focused on Asia and Africa, with one of the region’s largest asset management businesses. For Morningstar, Prudential’s business interests in Hong Kong and Singapore show that it has begun to move away from its bread and butter of catering to the middle classes to build a growing network of high-net-worth individuals. Key Morningstar Metrics For Adyen Analyst: Niklas Kammer, CFA Morningstar Rating: ★★★ Fair Value Estimate: EUR 1660.00 Economic Moat: Wide Niklas Kammer, equity analyst at Morningstar, considers the Dutch payment company to be an investment that provides exposure to the same attractive growth fundamentals that global tech giants enjoy. Also, the business does not have high capital requirements, it is profitable and is a high cash generator. Key Healthcare Stock Picks Bayer GSK Roche Key Morningstar Metrics For Bayer Analyst: Jay Lee Morningstar Rating: ★★★★★ Fair Value Estimate: EUR 45.10 Economic Moat: Narrow Morningstar analysts believe Bayer has a narrow economic moat because of the competitive advantages of the healthcare group. Bayer runs a crop science and consumer healthcare business which differs from its prescription drug offering. In the healthcare division, Bayer’s strong lineup of recently launched drugs and solid exposure to biologics support steady long-term cash flows. The company also holds leading brands Aspirin and Aleve. Bayer’s crop science segment includes crop protection products such as pesticides, and the fast-growing plant and seed biotechnology business. Key Morningstar Metrics For GSK Analyst: Jay Lee Morningstar Rating: ★★★★★ Fair Value Estimate: GBX 2200.00 Economic Moat: Wide Jay Lee, senior equity analyst at Morningstar, is backing undervalued GSK because of its next-generation respiratory and HIV drugs, which Lee expects to have strong growth over the next three years. Also, the firm’s respiratory syncytial virus vaccine Arexvy should support long-term growth because of the efficacy of the drug and limited competition. Key Morningstar Metrics For Roche Analyst: Karen Andersen, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: CHF 379.00 Economic Moat: Wide Karen Andersen, director of equity research at Morningstar, believes that Roche’s ROG drug portfolio and industry-leading diagnostics create maintainable competitive advantages for the company. Andersen also points to its culture of collaboration with its US arm Green Tech which has boosted research and development productivity, as well as personalized medicine offerings that take advantage of Roche’s diagnostic expertise. Key Industrials Stock Picks Rentokil Initial Melrose Industries Renault Key Morningstar Metrics For Rentokil Initial Analyst: Grant Slade, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: GBX 620.00 Economic Moat: Wide The UK-based pest-control business, Rentokil, is well positioned, according to Morningstar, to benefit from fast-growing pest-control demand in Asia. The stock is expected to grow from the gradual adoption of its digital-pest control offering, and from its ongoing M&A program, which has seen the business complete over 200 acquisitions since 2015. Key Morningstar Metrics for Melrose Industries Analyst: Loredana Muharremi, CFA Morningstar Rating: ★★★★ Fair Value Estimate: GBX 740.00 Economic Moat: Wide Aerospace business Melrose Industries supplies 90% of the in-service global engines fleet. The business focuses on narrow-body aircraft, and through its acquired business GKN Aerospace, it is also primed to capitalize on long-term structural industry growth. Its service business should also grow as 45% of CFM56 and 30% of V2500 engines are due for their first maintenance work over the next five years. Key Morningstar Metrics for Renault Analyst: Rella Suskin, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: EUR 85.00 Economic Moat: None No-moats Nissan and Honda have announced they are in talks to possibly merge with Renault. Rella Suskin, equity analyst at Morningstar, views the merger as a positive for Renault. A merged entity would benefit from greater scale. Renault has successfully streamlined its cost base at lightning speed over the last three years. These learnings could be applied to a merged Nissan-Honda company. Key Utilities Stock Picks SSE Veolia Environnement E.ON Key Morningstar Metrics For SSE Analyst: Tancrede Fulop, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: GBX 2350.00 Economic Moat: None Tancrede Fulop believes that UK utility SSE is well placed to benefit from the green transition accelerated by the election of the Labour government in Britain. In comparison to other Western European countries, the UK has a favorable regulatory regime which is a positive landscape for SSE. Key Morningstar Metrics for Veolia Environnement Analyst: Tancrede Fulop, CFA Morningstar Rating: ★★★★ Fair Value Estimate: EUR 37.50 Economic Moat: Narrow Treatment and distribution of water accounts for about 40% of Veolia’s turnover. The water distribution activity is not cyclical and is indexed to inflation. Also, water technologies make up 25% of the water division. According to Fulop, Veolia exhibits an economic moat thanks to switching costs as the business has “razor-and-blade” features driving highly recurring revenue. Key Morningstar Metrics for E.ON Analyst: Tancrede Fulop, CFA Morningstar Rating: ★★★★★ Fair Value Estimate: EUR 17.00 Economic Moat: Narrow E.ON is backed by Fulop because the company is absorbing additional investment opportunities due to the need to connect a growing amount of renewable capacity to the grid. The business is exposed to rising interest rates due to its exposure to pensions and the nuclear provisions it bears, and the network’s revenue is indexed to inflation.
Yesterday I listened to four trading podcasts while hiking. The theme was rebuilding Ukraine using Poland ETFs as big beneficiaries and two commodity ETF baskets at ATHs, any thoughts on commodities and Poland?